Global Blood Therapeutics, Inc.
(NASDAQ : GBT)

( )
GBT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 1.59%182.510.7%$1411.48m
MRKMerck & Co., Inc. 1.39%93.280.7%$1241.52m
PFEPfizer Inc. 3.21%51.700.9%$1234.19m
BMYBristol-Myers Squibb Co. 1.67%78.991.0%$1137.41m
LLYEli Lilly & Co. 4.15%325.691.1%$1136.04m
ABBVAbbVie, Inc. 2.07%152.551.9%$1019.26m
AZNAstraZeneca Plc 3.80%66.901.0%$452.09m
SGENSeagen Inc. 3.06%179.335.7%$326.01m
GSKGSK Plc 2.20%43.690.2%$297.44m
TPTXTurning Point Therapeutics, Inc. 0.03%75.170.0%$291.93m
SIGASIGA Technologies, Inc. -0.46%13.040.0%$219.68m
MRTXMirati Therapeutics, Inc. 3.45%68.161.6%$199.41m
HZNPHorizon Therapeutics Plc 2.68%85.135.4%$182.59m
NVSNovartis AG 3.62%84.820.2%$167.75m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -0.14%144.000.0%$147.86m

Company Profile

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.